Previous Close | 0.7297 |
Open | 0.6900 |
Bid | 0.6701 x 100 |
Ask | 0.7997 x 100 |
Day's Range | 0.6900 - 0.7744 |
52 Week Range | 0.6500 - 1.6100 |
Volume | |
Avg. Volume | 97,076 |
Market Cap | 12.857M |
Beta (5Y Monthly) | 0.31 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.7000 |
Earnings Date | Nov 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.17 |
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. Marina S. Bozilenko and Dr. Debra Yu as additional independent non-executive directors of the company with effect from November 25, 2024.
Talphera ( NASDAQ:TLPH ) Third Quarter 2024 Results Key Financial Results Net loss: US$3.35m (loss widened by 137% from...